AIkido Pharma Inc. reported that, on April 20, 2022, the independent Proxy Paper analysis firm Glass Lewis issued a report ("GL Report") providing an...
AIkido Pharma Inc. announced that the Company has secured an early equity interest in privately-held Yanka Industries, Inc., doing business as MasterClass . MasterClass...
AIkido Pharma Inc. reported an improvement in the manufacturing process for its pancreatic cancer drug, DHA-dFdC, licensed from the University of Texas at Austin....
